Literature DB >> 15876361

Inflammation and atherosclerosis in rheumatoid arthritis.

Robert J Stevens1, Karen M J Douglas, Athanasios N Saratzis, George D Kitas.   

Abstract

Rheumatoid arthritis (RA) associates with increased cardiovascular mortality. This appears to be predominantly due to ischaemic causes, such as myocardial infarction and congestive heart failure. The higher prevalence of cardiac ischaemia in RA is thought to be due to the accelerated development of atherosclerosis. There are two main reasons for this, which might be inter-related: the systemic inflammatory load, characteristic of RA; and the accumulation in RA of classical risk factors for coronary heart disease, which is reminiscent of the metabolic syndrome. We describe and discuss in the context of RA the involvement of local and systemic inflammatory processes in the development and rupture of atherosclerotic plaques, as well as the role of individual risk factors for coronary heart disease. We also present the challenges facing the clinical and scientific communities addressing this problem, which is receiving increasing attention.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15876361     DOI: 10.1017/S1462399405009154

Source DB:  PubMed          Journal:  Expert Rev Mol Med        ISSN: 1462-3994            Impact factor:   5.600


  36 in total

Review 1.  Rheumatoid cachexia and cardiovascular disease.

Authors:  Gregory D Summers; Giorgos S Metsios; Antonios Stavropoulos-Kalinoglou; George D Kitas
Journal:  Nat Rev Rheumatol       Date:  2010-07-20       Impact factor: 20.543

2.  Metabolic syndrome is common among middle-to-older aged Mediterranean patients with rheumatoid arthritis and correlates with disease activity: a retrospective, cross-sectional, controlled, study.

Authors:  S A Karvounaris; P I Sidiropoulos; J A Papadakis; E K Spanakis; G K Bertsias; H D Kritikos; E S Ganotakis; D T Boumpas
Journal:  Ann Rheum Dis       Date:  2006-06-22       Impact factor: 19.103

Review 3.  Cardiovascular risk in rheumatoid arthritis: assessment, management and next steps.

Authors:  Thomas Zegkos; George Kitas; Theodoros Dimitroulas
Journal:  Ther Adv Musculoskelet Dis       Date:  2016-04-30       Impact factor: 5.346

4.  Rheumatoid arthritis is sufficient to cause atheromatosis but not arterial stiffness or hypertrophy in the absence of classical cardiovascular risk factors.

Authors:  Aikaterini Arida; Evi Zampeli; George Konstantonis; Kalliope Fragiadaki; George D Kitas; Athanasios D Protogerou; Petros P Sfikakis
Journal:  Clin Rheumatol       Date:  2015-03-11       Impact factor: 2.980

5.  Vascular function and inflammation in rheumatoid arthritis: the role of physical activity.

Authors:  George S Metsios; Antonios Stavropoulos-Kalinoglou; Aamer Sandoo; Jet J C S Veldhuijzen van Zanten; Tracey E Toms; Holly John; George D Kitas
Journal:  Open Cardiovasc Med J       Date:  2010-02-23

6.  Redefining overweight and obesity in rheumatoid arthritis patients.

Authors:  Antonios Stavropoulos-Kalinoglou; Giorgos S Metsios; Yiannis Koutedakis; Alan M Nevill; Karen M Douglas; Athanasios Jamurtas; Jet J C S Veldhuijzen van Zanten; Mourad Labib; George D Kitas
Journal:  Ann Rheum Dis       Date:  2007-02-08       Impact factor: 19.103

7.  Derangement of hemostasis in rheumatoid arthritis: association with demographic, inflammatory and metabolic factors.

Authors:  Theodoros Dimitroulas; Karen M J Douglas; Vasileios F Panoulas; Tracey Toms; Jacqueline P Smith; Gareth J Treharne; Peter Nightingale; James Hodson; George D Kitas
Journal:  Clin Rheumatol       Date:  2013-05-15       Impact factor: 2.980

8.  Rheumatoid cachexia is associated with dyslipidemia and low levels of atheroprotective natural antibodies against phosphorylcholine but not with dietary fat in patients with rheumatoid arthritis: a cross-sectional study.

Authors:  Ann-Charlotte Elkan; Niclas Håkansson; Johan Frostegård; Tommy Cederholm; Ingiäld Hafström
Journal:  Arthritis Res Ther       Date:  2009-03-10       Impact factor: 5.156

9.  Lack of association between glucocorticoid use and presence of the metabolic syndrome in patients with rheumatoid arthritis: a cross-sectional study.

Authors:  Tracey E Toms; Vasileios F Panoulas; Karen M J Douglas; Helen R Griffiths; George D Kitas
Journal:  Arthritis Res Ther       Date:  2008-12-17       Impact factor: 5.156

10.  Methotrexate therapy associates with reduced prevalence of the metabolic syndrome in rheumatoid arthritis patients over the age of 60- more than just an anti-inflammatory effect? A cross sectional study.

Authors:  Tracey E Toms; Vasileios F Panoulas; Holly John; Karen M J Douglas; George D Kitas
Journal:  Arthritis Res Ther       Date:  2009-07-16       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.